Galectin Therapeutics Inc. (MUN:PHPN) Financings
Financings
| Raise | Date |
|---|---|
| Unsecured, convertible line of credit Announced: convertible Buyers: Richard E. Uihlein (Chairman; provides a new $10 million unsecured, convertible line of credit) Insiders: Line of credit provided by the company's chairman, Richard E. Uihlein Use of proceeds: Together with cash, to fund currently expected expenditures through at least March 2027 | Dec 19, 2025 |
| Convertible promissory notes under an unsecured line of credit, with stock purchase warrants Announced: up to 200,000 stock purchase warrants (20,000 per $1 million of borrowings), exercise… Buyers: Richard E. Uihlein (Provides the new $10 million unsecured convertible line of credit) Insiders: The credit line is provided by Richard E. Uihlein, Chairman of the Board and largest individual stockholder Use of proceeds: To cover projected expenditures through June 2026 | Jul 9, 2025 |